SCHEMBL3595571

SCHEMBL3595571

Cc1nn(C)c(Cl)c1S(=O)(=O)N1CCCCC1CN1CCN(C(=O)O)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FPR2 P25090 7/20 0.41
PROKR1 Q8TCW9 7/20 0.41
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ALDH1A1 P00352 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
PSEN1 P49768 2/20 0.35
PSEN2 P49810 2/20 0.35
APH1B Q8WW43 2/20 0.35
NCSTN Q92542 2/20 0.35
APH1A Q96BI3 2/20 0.35
PSENEN Q9NZ42 2/20 0.35
MEN1 O00255 1/20 0.35
USP2 O75604 1/20 0.35
LMNA P02545 1/20 0.35
TSHR P16473 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13036995 0.81 PSEN1 (0.53) FPR2PROKR1ALDH1A1PSEN1PSEN2
SCHEMBL3591997 0.80 ALDH1A1 (0.47) L3MBTL1ALDH1A1MEN1USP2LMNA
SCHEMBL3596139 0.79 KMT2A (0.47) FPR2PROKR1ALDH1A1MEN1KMT2A
SCHEMBL3592514 0.77 TP53 (0.37) ALDH1A1KMT2ACASP3
SCHEMBL3598308 0.74 NAMPT (0.40) ALDH1A1NPSR1PSEN1PSEN2APH1B
SCHEMBL2569567 0.74 BDKRB1 (0.44) FPR2PROKR1L3MBTL1PSEN1PSEN2
SCHEMBL3582654 0.73 CD274 (0.42) LMNATSHRKMT2A
SCHEMBL3584781 0.73 NAMPT (0.38) ALDH1A1MEN1KMT2ACASP3
SCHEMBL3580892 0.71 GAA (0.34) SMN1; SMN2CASP3GAA
SCHEMBL27900173 0.70 FPR2 (0.45) FPR2PROKR1L3MBTL1ALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090018117-A1 2-CARBAMIDE-4-PHENYLTHIAZOLE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2009-01-15 US claimed
US-7825112-B2 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof SANOFI-AVENTIS (FR) 2010-11-02 US disclosed
US-20090018117-A1 2-CARBAMIDE-4-PHENYLTHIAZOLE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2009-01-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090018117-A1 2-CARBAMIDE-4-PHENYLTHIAZOLE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF PKD2, QPCT, CCNT2 FPR2 1146/4885PROKR1 2210/4885ATM 1714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.